Literature DB >> 35678402

Neuropsychological Assessment in Dementia Diagnosis.

Sandra Weintraub.   

Abstract

PURPOSE OF REVIEW: This article discusses the application of neuropsychological evaluation to the workup of individuals with age-related cognitive impairment and suspected dementia. Referral questions, principles of evaluation, and common instruments to detect abnormalities in cognition and behavior in this population are reviewed. The integration of neuropsychological test findings with other clinical and biomarker information enhances early detection, differential diagnosis, and care planning. RECENT
FINDINGS: Life expectancy is increasing in the United States, and, accordingly, the prevalence and incidence of dementia associated with age-related neurodegenerative brain disease are rising. Age is the greatest risk factor for the dementia associated with Alzheimer disease, the most common neurodegenerative cause of dementia in people over 65 years of age; other etiologies, such as the class of frontotemporal lobar degenerations, are increasingly recognized in individuals both younger and older than 65 years of age. The clinical dementia diagnosis, unfortunately, is imperfectly related to disease etiology; however, probabilistic relationships can aid in diagnosis. Further, mounting evidence from postmortem brain autopsies points to multiple etiologies. The case examples in this article illustrate how the neuropsychological evaluation increases diagnostic accuracy and, most important, identifies salient cognitive and behavioral symptoms to target for nonpharmacologic intervention and caregiver education and support. Sharing the diagnosis with affected individuals is also discussed with reference to prognosis and severity of illness.
SUMMARY: The clinical neuropsychological examination facilitates early detection of dementia, characterizes the level of severity, defines salient clinical features, aids in differential diagnosis, and points to a pathway for care planning and disease education.
Copyright © 2022 American Academy of Neurology.

Entities:  

Mesh:

Year:  2022        PMID: 35678402      PMCID: PMC9492323          DOI: 10.1212/CON.0000000000001135

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  25 in total

1.  Three words three shapes: A clinical test of memory.

Authors:  S Weintraub; G M Peavy; M O'Connor; N A Johnson; D Acar; J Sweeney; I Janssen
Journal:  J Clin Exp Neuropsychol       Date:  2000-04       Impact factor: 2.475

2.  Acculturation, reading level, and neuropsychological test performance among African American elders.

Authors:  Jennifer J Manly; Desiree A Byrd; Pegah Touradji; Yaakov Stern
Journal:  Appl Neuropsychol       Date:  2004

3.  The Activities of Daily Living Questionnaire: a validation study in patients with dementia.

Authors:  N Johnson; A Barion; A Rademaker; G Rehkemper; S Weintraub
Journal:  Alzheimer Dis Assoc Disord       Date:  2004 Oct-Dec       Impact factor: 2.703

4.  Mild cognitive impairment: a concept in evolution.

Authors:  R C Petersen; B Caracciolo; C Brayne; S Gauthier; V Jelic; L Fratiglioni
Journal:  J Intern Med       Date:  2014-03       Impact factor: 8.989

5.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

6.  Verbal and nonverbal memory in primary progressive aphasia: the Three Words-Three Shapes Test.

Authors:  Sandra Weintraub; Emily Rogalski; Emily Shaw; Sabrina Sawlani; Alfred Rademaker; Christina Wieneke; M-Marsel Mesulam
Journal:  Behav Neurol       Date:  2013       Impact factor: 3.342

Review 7.  Measuring Behavior and Social Cognition in FTLD.

Authors:  Katherine P Rankin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  The clinical spectrum of sporadic and familial forms of frontotemporal dementia.

Authors:  Ione O C Woollacott; Jonathan D Rohrer
Journal:  J Neurochem       Date:  2016-06-15       Impact factor: 5.372

9.  High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis.

Authors:  Suzanne E Schindler; James G Bollinger; Vitaliy Ovod; Kwasi G Mawuenyega; Yan Li; Brian A Gordon; David M Holtzman; John C Morris; Tammie L S Benzinger; Chengjie Xiong; Anne M Fagan; Randall J Bateman
Journal:  Neurology       Date:  2019-08-01       Impact factor: 11.800

10.  Normative data for the Brief Cognitive Screening Battery stratified by age and education.

Authors:  Mônica Sanches Yassuda; Henrique Salmazo da Silva; Thais Bento Lima-Silva; Meire Cachioni; Deusivania Vieira da Silva Falcão; Andrea Lopes; Samila Sathler Tavares Batistoni; Anita Liberalesso Neri
Journal:  Dement Neuropsychol       Date:  2017 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.